Edwards Lifesciences Corporation (EW) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

Earnings Reports

• Edwards Lifesciences (EW) Q2 2026: TMTT Jumps 45% as Multi-Platform Portfolio Drives Durable Growth
  July 24, 2026
• Edwards Lifesciences (EW) Q4 2025: TMTT Grows 40% as Mitral and Tricuspid Pipeline Unlocks Multi-Year Opportunity
  June 15, 2026
• Edwards Lifesciences (EW) Q4 2025: TMTT Grows 40% as Guideline Shifts Fuel Durable Share Gains
  June 15, 2026
• Edwards Lifesciences (EW) Q4 2025: TMTT Grows 40%, Expanding Next-Gen Valve Leadership
  June 15, 2026
• Edwards Lifesciences (EW) Q1 2026: TMTT Grows 42%, Multi-Therapy Portfolio Drives Guidance Raise
  April 24, 2026
• Edwards Lifesciences (EW) Q3 2025: TMTT Accelerates 53%, Expanding Structural Heart Growth Pipeline
  October 31, 2025
• Edwards Lifesciences (EW) Q2 2025: TMTT Sales Surge 57% as Portfolio Expansion Outpaces Market
  July 24, 2025
• Edwards Lifesciences (EW) Q1 2025: TMTT Sales Jump 60%, Fueling Portfolio-Driven Growth Outlook
  July 01, 2025

Browse all companies